Yale School of Medicine: Large NIH Grant Supports CRISPR-Based Gene Therapy Development for Brain Diseases
October 04, 2023
October 04, 2023
NEW HAVEN, Connecticut, Oct. 4 (TNSres) -- The Yale University School of Medicine issued the following news:
The two-phase grant will fund research into a new CRISPR-based gene therapy platform that will target genetic brain diseases such as Angelman syndrome and H1-4 (HIST1H1E) syndrome.
A roughly $40 million National Institutes of Health (NIH) grant awarded to Yale School of Medicine will support the development of a gene-editing platform technology capable of reachin . . .
The two-phase grant will fund research into a new CRISPR-based gene therapy platform that will target genetic brain diseases such as Angelman syndrome and H1-4 (HIST1H1E) syndrome.
A roughly $40 million National Institutes of Health (NIH) grant awarded to Yale School of Medicine will support the development of a gene-editing platform technology capable of reachin . . .